Почетна › Кронова болест › Konektikat
Kliničke studije za Кронова болест u državi Konektikat
12 studija za Кронова болест traži učesnike na lokacijama u državi Konektikat.
Gradovi u državi Konektikat
Zvanični tekst studije (na engleskom)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Connecticut Clinical Research Institute ( Site 0297), Bristol
Тражи се учесникФаза 3
Сви узрасти · Оба пола · Ажурирано 10. 11. 2026. · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Yale University School of Medicine-Digestive Disease ( Site 5019), New Haven
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Connecticut Children's Medical Center, Hartford
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Medical Research Center of Connecticut, Hamden
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Yale University Digestive Disease-Site Number: 8400108, New Haven
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Connecticut Children's Medical Center, Hartford
Тражи се учесникФаза 3
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Connecticut Children's Medical Center, Hartford
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 7. 10. 2026. · NCT05509777Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Danbury Hospital, Western Connecticut Health Network /ID# 265556, Danbury
- Yale University School of Medicine /ID# 266786, New Haven
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Yale University, New Haven
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Yale University School of Medicine, New Haven
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07237516Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
- Connecticut Children's Medical Center, Hartford
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 10 до 21 · Оба пола · Ажурирано 16. 7. 2026. · NCT07224113Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.